McKesson Corporation vs Oxford Lane Capital Corp — how do they compare? McKesson Corporation trades at $832.45 (market cap $97.35B), while Oxford Lane Capital Corp trades at $8.82 (market cap $866.15M). The key difference: McKesson Corporation is far larger — about 112.4× Oxford Lane Capital Corp's market cap, and Oxford Lane Capital Corp pays the higher dividend (27.06%). Which is the better fit depends on your goals.
| MCK | OXLC | |
|---|---|---|
Market Cap | $97.35B | $866.15M |
Sector | Health | Financials |
52-Week High | $995.69 | $19.90 |
52-Week Low | $659.01 | $8.15 |
Enterprise Value | $101.98B | — |
Dividend Yield | 0.39% | 27.06% |
Trailing returns across standard periods
Latest headlines on both assets
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →